These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1273 related articles for article (PubMed ID: 20167849)

  • 1. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR gene mutations in adults with disseminated bronchiectasis.
    Girodon E; Cazeneuve C; Lebargy F; Chinet T; Costes B; Ghanem N; Martin J; Lemay S; Scheid P; Housset B; Bignon J; Goossens M
    Eur J Hum Genet; 1997; 5(3):149-55. PubMed ID: 9272738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
    Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A
    Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
    Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
    Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M
    Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
    Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M
    Respiration; 2006; 73(5):698-704. PubMed ID: 16763370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic fibrosis and normal sweat chloride values: a case-report].
    Lebecque P; Leal T; Godding V
    Rev Mal Respir; 2001 Sep; 18(4 Pt 1):443-5. PubMed ID: 11547256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
    Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
    N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
    Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
    J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
    Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'ava-Santucci J; Dusser D
    J Cyst Fibros; 2004 Mar; 3(1):15-22. PubMed ID: 15463882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease.
    Gonska T; Choi P; Stephenson A; Ellis L; Martin S; Solomon M; Dupuis A; Dorfman R; Zielenski J; Ooi CY; Weiser W; Durie PR; Tullis E
    Chest; 2012 Oct; 142(4):996-1004. PubMed ID: 22423042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
    Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
    N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
    Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
    Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.